XML 80 R23.htm IDEA: XBRL DOCUMENT
v2.4.0.8

16. Segment Information | 3 Months Ended | 12 Months Ended
--- | --- | ---
Mar. 31, 2014 | Dec. 31, 2013
Segment Information |  |
NOTE 16 - Segment Information | In 2013, ProElite was considered to be an operating segment pursuant to ASC Topic 280 “Segment Reporting” since each was budgeted separately and tracked separately to provide the chief operating decision maker information to assess and manage ProElite, Stratus White and Hygeia/Canterbury. The Company suspended operations of ProElite effective June 30, 2013. Following the repositioning of the Company as a specialty biopharmaceutical company, the Company’s Board of Directors voted to discontinue operations of ProElite effective March 31, 2014. The following segment information is presented to provide a comparison for the three months ended March 31, 2014 and 2013. A summary of results by segments is as follows:
|  | Three Months Ended March 31, 2014 ($000) |  |  | Three Months Ended March 31, 2013 ($000) |
|  | Bio- |  |  | ProElite |  |  |  |  |  |  |  |  | Bio- |  |  | ProElite |  |  |  |  |  |  |
|  | Pharma |  |  | (Discont.) |  |  | Other |  |  | Total |  |  | Pharma |  |  | (Discont.) |  |  | Other |  |  | Total |
Revenues |  | $ | – |  |  | $ | – |  |  | $ | – |  |  | $ | – |  |  | $ | – |  |  | $ | – |  |  | $ | – |  |  | $ | – |
Cost of sales |  |  | – |  |  |  | – |  |  |  | – |  |  |  | – |  |  |  | – |  |  |  | – |  |  |  | – |  |  |  | – |
Gross margin |  |  | – |  |  |  | – |  |  |  | – |  |  |  | – |  |  |  | – |  |  |  | – |  |  |  | – |  |  |  | – |
Deprec. & Amort |  |  | 1 |  |  |  | – |  |  |  | 477 |  |  |  | 478 |  |  |  | – |  |  |  | – |  |  |  | 9 |  |  |  | 9 |
Segment profit |  |  | (1 | ) |  |  | – |  |  |  | (477 | ) |  |  | (478 | ) |  |  | – |  |  |  | – |  |  |  | (9 | ) |  |  | (9 | )
Operating expenses |  |  | 183 |  |  |  | – |  |  |  | 710 |  |  |  | 893 |  |  |  | – |  |  |  | – |  |  |  | 2,084 |  |  |  | 2,084 |
Other (income)/expenses |  |  | – |  |  |  | – |  |  |  | 5 |  |  |  | 5 |  |  |  | – |  |  |  | – |  |  |  | 20 |  |  |  | 20 |
Impact of derivative securities |  |  | – |  |  |  | – |  |  |  | – |  |  |  | – |  |  |  | – |  |  |  | – |  |  |  | 237 |  |  |  | 237 |
Net loss from continuing ops. |  |  | (184 | ) |  |  | – |  |  |  | (1,192 | ) |  |  | (1,376 | ) |  |  | – |  |  |  | – |  |  |  | (2,350 | ) |  |  | (2,350 | )
Loss from discontinued ops. |  |  | – |  |  |  | – |  |  |  | – |  |  |  | – |  |  |  | – |  |  |  | (127 | ) |  |  | – |  |  |  | (127 | )
Preferred dividends |  |  | – |  |  |  | – |  |  |  | – |  |  |  | – |  |  |  | – |  |  |  | – |  |  |  | 124 |  |  |  | 124 |
Net loss attributable to common shareholders |  | $ | (184 | ) |  | $ | – |  |  | $ | (1,192 | ) |  | $ | (1,376 | ) |  | $ | – |  |  | $ | (127 | ) |  | $ | (2,474 | ) |  | $ | (2,601 | )
Assets at End of Period |  | $ | 230 |  |  | $ | 344 |  |  | $ | 25,878 |  |  | $ | 26,452 |  |  | $ | – |  |  | $ | 1,677 |  |  | $ | 511 |  |  | $ | 2,188 |
Liabilities at End of Period |  | $ | 2,779 |  |  | $ | 625 |  |  | $ | 7,291 |  |  | $ | 10,695 |  |  | $ | – |  |  | $ | 1,998 |  |  | $ | 19,927 |  |  | $ | 21,925 |
| In 2013, ProElite, Stratus White and Hygeia/Canterbury were considered operating segments pursuant to ASC Topic 280 “Segment Reporting” since each was budgeted separately and tracked separately to provide the chief operating decision maker information to assess and manage ProElite, Stratus White and Hygeia/Canterbury. In 2012, ProElite and Stratus White were considered operating segments. In 2012, the Company decided to suspend development of all business activities other than ProElite and effective June 30, 2013, the Company decided to suspend development of its ProElite business. A summary of results by segments is as follows:
|  | As of/for the Year Ended December 31, 2013 |  |  | As of /for the Year Ended December 31, 2012 |
|  | Stratus Rewards |  |  | ProElite |  |  | Life Sciences |  |  | Other |  |  | Total |  |  | Stratus Rewards |  |  | ProElite |  |  | Other Events |  |  | Other |  |  | Total |
Revenues |  | $ | – |  |  | $ | 72 |  |  | $ | – |  |  | $ | – |  |  | $ | 72 |  |  | $ | – |  |  | $ | 375 |  |  | $ | – |  |  | $ | – |  |  | $ | 375 |
Cost of sales |  |  | – |  |  |  | – |  |  |  | – |  |  |  | – |  |  |  | – |  |  |  | – |  |  |  | 236 |  |  |  | – |  |  |  | – |  |  |  | 236 |
Gross margin |  |  | – |  |  |  | 72 |  |  |  | – |  |  |  | – |  |  |  | 72 |  |  |  | – |  |  |  | 139 |  |  |  | – |  |  |  | – |  |  |  | 139 |
Deprec. & Amort |  |  | – |  |  |  | 2 |  |  |  | 87 |  |  |  | 587 |  |  |  | 676 |  |  |  | – |  |  |  | 2 |  |  |  | – |  |  |  | 32 |  |  |  | 34 |
Segment profit |  |  | – |  |  |  | 70 |  |  |  | (87 | ) |  |  | (587 | ) |  |  | (604 | ) |  |  | – |  |  |  | 137 |  |  |  | – |  |  |  | (32 | ) |  |  | 105 |
Operating expenses |  |  | 85 |  |  |  | 192 |  |  |  | 80 |  |  |  | 12,371 |  |  |  | 12,728 |  |  |  | 1,724 |  |  |  | 990 |  |  |  | – |  |  |  | 9,183 |  |  |  | 11,897 |
Other (income) expenses |  |  | – |  |  |  | (714 | ) |  |  | – |  |  |  | 643 |  |  |  | (71 | ) |  |  | – |  |  |  | 97 |  |  |  | – |  |  |  | 1,763 |  |  |  | 1,859 |
Impact of derivative securities |  |  | – |  |  |  | – |  |  |  | – |  |  |  | (10,459 | ) |  |  | (10,459 | ) |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (6,801 | ) |  |  | (6,801 | )
Net loss |  | $ | (85 | ) |  | $ | 592 |  |  | $ | (167 | ) |  | $ | (3,142 | ) |  |  | (2,802 | ) |  | $ | (1,724 | ) |  | $ | (950 | ) |  | $ | – |  |  | $ | (4,177 | ) |  | $ | (6,850 | )
Net loss attributable to non-controlling interests |  |  | – |  |  |  | – |  |  |  | – |  |  |  | (6 | ) |  |  | (6 | ) |  |  | – |  |  |  | – |  |  |  | – |  |  |  | (19 | ) |  |  | (19 | )
Preferred dividend |  |  | – |  |  |  | – |  |  |  | – |  |  |  | (172 | ) |  |  | (172 | ) |  |  | – |  |  |  | – |  |  |  | – |  |  |  | 497 |  |  |  | 497 |
Net loss attributable to common shareholders |  | $ | (85 | ) |  | $ | 592 |  |  | $ | (167 | ) |  | $ | (2,976 | ) |  | $ | (2,636 | ) |  | $ | (1,724 | ) |  | $ | (950 | ) |  | $ | – |  |  | $ | (4,693 | ) |  | $ | (7,366 | )
Assets |  | $ | – |  |  | $ | 230 |  |  | $ | 572 |  |  | $ | 17,542 |  |  | $ | 18,344 |  |  | $ | – |  |  | $ | 2,161 |  |  | $ | – |  |  | $ | 285 |  |  | $ | 2,446 |
Liabilities |  | $ | 52 |  |  | $ | 2,779 |  |  | $ | 587 |  |  | $ | 5,460 |  |  | $ | 8,878 |  |  | $ | 122 |  |  | $ | 2,632 |  |  | $ | 2,271 |  |  | $ | 15,828 |  |  | $ | 20,853 |

X
- Details
Name: | RESX_SegmentInformationAbstract
Namespace Prefix: | RESX_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 29 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8864-108599 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8933-108599 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 26 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8844-108599 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 10 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8538-108599 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8380-108599 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 34 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8981-108599 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 35 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8984-108599 Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 41 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9038-108599 Reference 9: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8906-108599 Reference 10: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 42 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9054-108599 Reference 11: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 31 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8924-108599 Reference 12: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 40 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9031-108599 Reference 13: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 33 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8971-108599 Reference 14: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 12 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8595-108599 + Details
Name: | us-gaap_SegmentReportingDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration